Mumbai, Sept. 3 -- In a regulatory filing made post market hours yesterday, the company said that RPG Active Pharma has entered into a business transfer agreement to acquire the active pharmaceutical ingredients (API) and intermediates business undertaking of Raghava Life Sciences.

The said acquisition is being done on a going-concern basis through a slump sale for a total cash consideration of up to Rs 135 crore. The transaction is subject to customary closing conditions and regulatory approvals.

RPG Active Pharma, a wholly owned subsidiary of RPG Life Sciences, has been established to build a focusedAPI business with capabilities across research-led product development. manufacturing and business development. The company is pursuing s...